Clinical Trials Directory

Trials / Completed

CompletedNCT05858294

The Safety, Acceptability and Efficacy of Alena

The Safety, Acceptability and Efficacy of Alena, a Modularized CBT-based Mobile App Intervention for Social Anxiety: a Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Aya Technologies Limited · Industry
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.

Detailed description

This is a 6-week web-based parallel-group unblinded randomised controlled trial with a 4-week intervention period and a 2-week follow-up post intervention. Participants are randomly allocated to receive access to the Alena CBT programme or to a wait list control group, in a 1:1 ratio. The programme consists of CBT-based therapy for social anxiety based on the Clark and Wells model.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral Therapy programmeThis mobile application comprised CBT-based therapy for social anxiety based on the Clark and Wells model

Timeline

Start date
2022-10-31
Primary completion
2022-12-04
Completion
2022-12-18
First posted
2023-05-15
Last updated
2023-05-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05858294. Inclusion in this directory is not an endorsement.